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OBJECTIVE: To identify demographic, clinical, and
biological characteristics of older nondisabled patients
who develop new disability in basic activities of daily
living (BADL) during medical illnesses requiring
hospitalization.
DESIGN: Longitudinal observational study.
SETTING: Geriatric and Internal Medicine acute care
units.
PARTICIPANTS: Data are from 1,686 patients aged 65
and older who independent in BADL 2 weeks before
hospital admission, enrolled in the 1998 survey of the
Italian Group of Pharmacoepidemiology in the Elderly
Study.
MEASUREMENTS: Study outcome was new BADL
disability at time of hospital discharge. Sociodemo-
graphic, functional status, and clinical characteristics
were collected at hospital admission; acute and chronic
conditions were classified according to the International
Classification of Disease, ninth revision; fasting blood
samples were obtained and processed with standard
methods.
RESULTS: A tt h et i m eo fh o s p i t a ld i s c h a r g e1 1 3
patients (6.7%) presented new BADL disability. Func-
tional decline was strongly related to patients’ age and
preadmission instrumental activities of daily living
status. In a multivariate analysis, older age, nursing
home residency, low body mass index, elevated eryth-
rocyte sedimentation rate, acute stroke, high level of
comorbidity expressed as Cumulative Illness Rating
Scale score, polypharmacotherapy, cognitive decline,
and history of fall in the previous year were independent
and significant predictors of BADL disability.
CONCLUSION: Several factors might contribute to loss
of physical independence in hospitalized older persons.
Preexisting conditions associated with the frailty syn-
drome, including physical and cognitive function,
comorbidity,bodycomposition, andinflammatory mark-
ers, characterize patients at high risk of functional
decline.
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INTRODUCTION
Decline in physical function is common in older persons
admitted to the hospital for medical events.
1,2 Besides the
disabling effect of the acute event, hospitalization itself might
represent an additional stressor in terms of environmental
hazard, reduced caloric intake, low physical activity or pro-
longed bed-rest, depressed mood, and social isolation.
3 More-
over, acute illnesses and hospitalization often trigger
functional decline in spite of adequate medical treatment of
the acute disease. Decline in functional status during hospi-
talization has important consequences in terms of quality of
life and health care utilization, as it has been associated with
the risk of longer hospital stay, home care placement, and
mortality.
1–5 Although some patients may quickly regain
autonomy after hospital discharge,
6 hospitalization has been
associated with the risk of incident disability at 6 and
18 months, suggesting that the functional change associated
with hospitalization might have important long-term conse-
quences.
7 Identification of patients at high risk of functional
decline is of paramount importance for the prevention of this
common negative outcome.
Previous studies have identified different risk factors for
worsening functional status, including older age, sociodemo-
graphic characteristics, preexisting disability, cognitive de-
cline, delirium, and comorbidity.
8–10 Conversely, the role of
biological characteristics and selected acute and chronic
diseases has not been systematically evaluated. Moreover,
most previous studies included patients who were already
disabled before hospital admission, but predictors might be
different in patients with different functional status.
The aim of this study was to evaluate the predictive value of
sociodemographic characteristics, functional and cognitive
status, acute and chronic conditions, global indicators of
comorbidity, and several biomarkers in identifying patients,
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668who were independent in basic activities of daily living (BADL),
at high risk of developing new disability during hospitalization.
We hypothesised that patients with the functional and clinical
characteristics of the frailty phenotype would be more likely to
experience functional decline associated to medical illnesses
requiring hospitalization.
METHODS
Patients
The protocol of the Italian Group of Pharmacoepidemiology in
the Elderly Study (GIFA) study has been described else-
where.
11 Briefly, the GIFA is a multicenter periodical survey
of hospitalized older patients, which started in 1988. All
patients admitted to 81 clinical centers homogeneously dis-
tributed throughout Italy were enrolled and followed until
discharge. For each participant, a questionnaire was complet-
ed at admission and updated daily by a study physician who
received specific training. Data recorded included demographic
characteristics; functional, cognitive, and mood assessment;
medications use; admission and discharge diagnoses; and
results of biochemical tests. In 1998, additional variables were
included in the study protocol (for example, instrumental
activities of daily living [IADL], Geriatric Depression Scale,
and history of falls) and therefore we limited this specific
project to patients enrolled during the 1998 survey.
In the 1998 survey, 3,746 patients were enrolled. Of them,
897 (23.9%) were younger than 65 years and were not
considered for the analysis. Three hundred and five (8.1%)
patients were then excluded because of missing data on
functional status (184, 4.9%) or because they died during
hospital stay (121, 3.2%). Of the remaining 2,544 (68%)
patients, 1,686 (45%) were independent in BADL 2 weeks
before hospitalization and represent our analytical sample.
Physical Function Evaluation
Functional status was evaluated by self-report information,
including 5 BADL (personal hygiene, transferring from bed to
chair, using the toilet, dressing, and eating) and 7 IADL (using
the telephone, grocery shopping, preparing meals, doing
housework, doing laundry, taking medications, managing
money, and using transportation systems). Patients or proxy
(15.8%) were interviewed at the time of hospital admission and
hospital discharge. Patients were asked to report whether,
2 weeks before hospital admission, they could perform each
activity independently. For every activity the level of depen-
dency was coded as follows: independent, supervision, limited
assistance, intensive assistance, and total dependency. The
degree of dependence in performing the BADL was also
assessed at time of hospital discharge. According to this
information, the onset of new BADL disability was defined as
being not fully independent in any of the 5 activities of daily
living (ADL) considered.
Covariates
Demographic characteristics and history of fall in the previous
year were collected from self-report information. Cognitive
function was assessed at admission using the Hodkinson
Abbreviated Mental Test, a 10-item screening test for demen-
tia. Cognitive impairment was defined as presence of 4 or more
errors on the test.
12 For 75% of patients with cognitive
impairment, ADL status was collected using proxy interview;
for the remaining 88 patients with cognitive impairments
(25%), the subgroup with less severe cognitive decline (4.7
average number of errors at the Hodkinson Abbreviated
Mental Test), information were collected from the patient. The
presence of significant depressive symptoms was defined by a
score of 5 or higher at the short form (15 items) of the Geriatric
Depression Scale (GDS).
13 Body mass index (BMI) was com-
puted using measured height and weight (kg/m
2). Values
below 18.5 were considered underweight, between 18.5 and
24.9 normoweight, between 25 and 29.9 overweight, and
values greater than 30 were considered as obesity.
14 All
diseases diagnosed by the trained physicians at discharge
were classified according to the International Classification of
Disease, ninth revision.
15 Six acute clinical conditions (acute
coronary syndrome, congestive heart failure, pneumonia,
stroke, chronic obstructive pulmonary disease [COPD] exacer-
bation, and infections) and seven chronic clinical conditions
(coronary heart disease, cerebrovascular disease, diabetes,
hypertension, cancer, COPD, and Parkinson) were considered.
To estimate the global burden of diseases and severity of
comorbidity, the Cumulative Illness Rating Scale (CIRS) and
the total number of drugs prescribed during hospital stay were
considered and analyzed as potential risk factors.
16 Among
selected medications, the use of anxiolytics, antipsychotics,
and antidepressants was considered as a potential risk factor
for functional decline.
All routine laboratory tests were determined the morning
after the first day after admission after an overnight 12-hour
fast. Assays were performed in the central laboratory of each
clinical center using standard enzymatic methods.
Statistical Analysis
Study participants were followed up until hospital discharge.
Characteristics hypothesized to be associated with functional
decline over hospitalization are listed in Table 2. For statistical
analysis, continuous variables were recoded into categorical
variables, according to predefined criteria when such criteria
where available (BMI, albumin, cholesterol, erythrocyte sedi-
mentation rate, number of drugs, Hodkinson Abbreviated
Mental Test score, and GDS score) or tertiles of distribution
(glucose, creatinine, and CIRS). A missing category was added
to all variables with 1 or more missing values: BMI (13.8%),
albumin (17.4%), cholesterol (11.5%), and erythrocyte sedi-
mentation rate (9.7%). Logistic regression models were used to
assess the association between potential risk factors for
functional decline and the likelihood of having new BADL
disability at hospital discharge. To control for the effect of age
and preadmission functional status, odds ratios and 95%
confidence interval (CI) were adjusted for age and IADL status.
Although strongly affected by cognitive function, IADL impair-
ment usually represents an early step in the disablement
process of older persons and may convey important informa-
tion for the identification of nondisabled person at high risk of
physical decline.
17 Candidate variables to be included in the
logistic model were selected on the basis of biological and
clinical plausibility as risk factor for functional decline. To
identify factors independently associated with the risk of new
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computed including all the variables that were associated with
the outcome at an α level of 0.1. Afterward, to obtain a more
parsimonious predictive model and to achieve a suitable ratio
of the number of events to the number of covariates,
18
unnecessary variables were removed using a backward step-
wise technique (P for removal .1). To quantify multicollinearity,
the variance inflation factor (VIF) was also computed. Finally,
the multivariable logistic regression model was validated by
means of bootstrapping technique. One thousand bootstrap
simulations were performed, producing 95% CI for the vari-
ables retained in the most parsimonious model.
RESULTS
Table 1 shows selected demographic and clinical character-
istics of the study participants. The mean age of the patients
was 77.4 years, 48.4% were women and 2.5% were nursing
home residents. Two weeks before hospital admission, 35.5%
were independent in all IADL, whereas 21% of the patients had
cognitive impairment at hospital admission. The mean length
of hospital stay was 11.2 days and cardiovascular disease was
the most common discharge diagnosis category (42%). Com-
pared to individuals included in the analysis, those excluded
were older, more likely to be men, and had a greater level of
comorbidity and cognitive impairment.
At hospital discharge 113 patients (6.7%) presented new
BADL disability; of them, 85% experienced functional decline
in 2 or more BADL. New BADL dependence was associated
with longer hospital stay (mean difference +2.8 days, P<.001)
and higher rate of discharge to a nursing home (8.9% vs 1.0,
P<.001). Transferring and dressing were the two activities
more frequently lost by the patients. The likelihood offunctional
decline was strongly related to patients’ age and IADL func-
tional status. For example, almost 1 out of 4 patients 85 years
and older and dependent in 5 or more IADL developed new
BADL disability over the study follow-up.
Logistic regression analysis, adjusted for age and IADL
status before admission, was used to screen variables hypoth-
esized to predict functional decline at discharge (Table 2).
Nursing home residency, low BMI, low albumin level, choles-
terol level, high erythrocyte sedimentation rate, cognitive
decline, the number of drugs, the CIRS score, and history of
fall in the previous year were all associated with the risk of new
BADL disability at a significance level <.1. Among the single
diseases considered, only stroke and pneumonia were associ-
ated with the onset of new disability. These variables, of the 35
tested initially, were entered into a multivariable logistic
regression model (Table 3). Older age, low BMI, high erythro-
cyte sedimentation rate, diagnosis of stroke, high level of
comorbidity (CIRS score), high number of medications, cogni-
tive decline, history of fall in the previous year, and baseline
IADL status were independent predictors of loss of one or more
BADL. The results were virtually unchanged after removal of
unnecessary variables (Table 3, most parsimonious model).
Overall, the binomial logistic model explained a remarkable
proportion of the variability (area under receiver operating
characteristic curve=0.805). Variance inflation factors analysis
suggested a low level of collinearity (average VIF for the final
model=1.38). Finally, to validate the final logistic model 1,000
bootstrap simulations were performed. In terms of the vari-
ables found to be significant in the original analysis, only
history of falls in the previous year had a 95% CI that was not
statistically significant (0.91–2.91).
DISCUSSION
The objective of this study was to identify factors associated
with the risk of new BADL disability in nondisabled older
patients admitted to the hospital for medical problems. After
testing a large number of potential predictors, older age,
nursing home residency, low BMI, high erythrocyte sedimen-
tation rate, cognitive decline, high level of comorbidity, and
history of falls in the previous year were identified as indepen-
dent predictors of new difficulty in at least one BADL at
hospital discharge. This study demonstrates that medical,
functional, and biological characteristics, usually linked with
the frailty phenotype,
19 are among the most important pre-
dictors of functional decline associated with hospitalization.
Indeed among the specific diseases leading to hospital admis-
sion, only acute stroke was identified as a significant predictor.
Results of this study are based on an in-depth multidimen-
sional assessment including various sociodemographics and
anthropometric, clinical, biochemical, and functional charac-
Table 1. Selected General and Clinical Characteristics of
Participant Included in the Study Sample (n = 1,686) and
Participants Excluded (n = 305)
Characteristic Included Excluded P value
Age, years; mean (standard
deviation)
77.4 (7.2) 79.6 (7.9) <.001
Women, n (%) 816 (48.4) 127 (41.6) .023
Educational level, years; mean
(standard deviation)
5.4 (3.6) 5.5 (3.6) .789
Living alone, n (%) 348 (20.6) 55 (18.0) .297
Admitted from nursing home,
n (%)
42 (2.5) 13 (4.3) .082
Smoking, n (%)
Former 671 (39.8) 133 (43.6)
Current 176 (10.4) 39 (12.8) .119
BMI, kg/m
2; mean (standard
deviation)
25.7 (4.6) 24.5 (4.9) .004
HAMT score mean (standard
deviation)
8.2 (1.9) 5.6 (3.8) <.001
GDS, mean (standard deviation) 4.9 (3.5) 4.4 (3.5) .021
Number of drugs, mean
(standard deviation)
8.2 (5.2) 9.5 (6.9) <.001
CIRS score, mean (standard
deviation)
8.4 (4.2) 10.3 (6.9) <.001
Number of independent IADL 2
week before admission,
mean (standard deviation)
4.9 (3.5) 4.5 (4.6) .022
Discharge diagnostic category,
n (%)
Cardiovascular 709 (42.0) 114 (37.4) .127
Cerebrovascular 146 (8.6) 28 (9.2) .767
Neurological 115 (6.8) 12 (3.9) .058
Pulmonary 118 (7.0) 23 (7.6) .734
Gastrointestinal 132 (7.9) 18 (5.9) .241
Cancer 67 (4.0) 30 (9.8) <.001
Others 399 (23.6) 80 (26.2) .335
Length of hospital stay, days;
mean (standard deviation)
11.2 (6.3) 14.8 (32.1) <.001
BMI = Body mass index, HAMT = Hodkinson Abbreviated Mental Test,
GD = Geriatric Depression Scale, Total Cumulative Illness Rating Scale
(CIRS)
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Variables No. of patients No. of events Percent OR (95% CI)*
Sociodemographics
Age
65–74 693 22 (3.2) 1 (Reference)
75–84 686 52 (7.6) 2.26 (1.35–3.80)†
≥84 307 39 (12.7) 3.49 (1.99–6.11)†
Women 816 63 (7.7) 0.86 (0.56–1.27)
Married 890 43 (4.8) 0.75 (0.50–1.15)
Living alone 348 24 (7.3) 1.02 (0.66–1.58)
Nursing Home resident 25 10 (40.0) 7.16 (3.00–17.1)
Education <5 yr 1,268 91 (7.2) 1.20 (0.72–2.00)
Biomarkers and BMI
BMI
<18.5 61 9 (14.8) 2.67 (1.18–6.03)†
18.5–24.9 600 32 (5.3) 1 (Reference)
25–29.9 563 18 (3.2) 0.65 (0.36–1.17)
≥30 229 8 (3.5) 0.72 (0.35–1.74)
Missing 233 46 (19.7) 4.04 (2.39–6.83)
Glucose (mg/dL)
≤89 561 34 6.1 1 (Reference)
90–118 560 34 6.1 0.95 (0.57–1.56)
≥118 565 45 8.0 1.36 (0.85–2.17)
Creatinine (mg/dL)
<0.9 552 34 (6.2) 1 (Reference)
≥0.9≤1.2 474 25 (5.3) 0.85 (0.49–1.45)
>1.2 660 54 (8.2) 1.29 (0.82–2.04)
Albumin
<3.5 g/dL 366 33 (9.0) 1.66 (1.05–2.62)
Missing 294 25 (8.5) 1.17 (0.67–2.08)
Total cholesterol (mg/dL)
<160 387 27 (7.0) 1 (Reference)
160–199 390 22 (5.6) 0.87 (0.48–1.57)
200–239 363 12 (3.3) 0.51 (0.25–1.02)†
≥240 164 8 (4.9) 0.80 (0.35–1.81)
Missing 382 44 (11.5) 1.42 (0.84–2.40)
Erythrocyte sedimentation rate
≥40 mm/h 383 38 (9.9) 1.81 (1.18–2.78)†
Missing 185 11 (5.9) 1.13 (0.57–2.22)
Anemia 662 51 (7.7) 1.26 (0.85–1.88)
Comorbidities
Acute conditions
Acute coronary syndrome 62 4 (6.5) 1.06 (0.37–3.02)
Congestive heart failure 318 12 (3.8) 0.73 (0.46–1.14)
COPD 44 4 (9.1) 1.20 (0.41–3.48)
Pneumonia 46 8 (17.4) 2.88 (1.25–6.62)†
Stroke 38 14 (36.8) 9.05 (4.34–18.9)†
Infections 79 3 (3.8) 0.54 (0.17–1.77)
Chronic conditions
Cancer 187 18 (6.6) 1.56 (0.91–2.68)
COPD 279 22 (7.9) 1.09 (0.66–1.80)
Cerebrovascular disease 214 24 (10.3) 1.42 (0.85–2.36)
Coronary heart disease 494 30 (6.1) 0.87 (0.56–1.35)
Diabetes 334 21 (6.3) 1.09 (0.66–1.80)
Hypertension 747 45 (6.0) 0.87 (0.59–1.30)
Parkinson 34 5 (14.7) 1.77 (0.64–4.85)
Total CIRS score
0–6 592 27 (4.6) 1 (Reference)
7–9 507 41 (8.1) 1.77 (1.06–2.96)†
≥10 587 45 (7.7) 1.63 (0.98–2.71)†
Medications
Anxiolytics 350 24 (6.9) 1.08 (0.67–1.73)
Antipsychotic 77 11 (15.1) 1.91 (0.94–3.86)†
Antidepressant 138 11 (8.1) 1.06 (0.54–2.07)
No. of drugs
0–4 363 13 (3.6) 1 (Reference)
5–7 522 23 (4.4) 1.14 (0.56–2.30)
≥8 801 77 (9.6) 2.50 (1.35–4.64)†
Cognitive and affective status
Cognitive decline (HAMT <7) 355 47 (13.2) 2.14 (1.41–3.26)†
Symptoms of depression (GDS ≥5) 603 32 (5.3) 0.94 (0.59–1.48)
(continued on next page)
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information of previous studies focusing mainly on selected
determinant of functional status in older patients.
10 The
findings of a number of characteristics independently pre-
dicting disability is consistent with the frequent clinical picture
of multiple contributing causes of poor health outcome in the
elderly. Moreover, our study focusing on patients without
disability at baseline, a subgroup that received less attention
in previous studies, might provide new and additional insights
on the pathological mechanism underlying functional decline
associated with medical illness and hospitalization.
Functional Status
Several studies investigated the role of sociodemographic and
clinical features as risk factors for functional decline during
Table 2. (continued)
Variables No. of patients No. of events Percent OR (95% CI)*
Functional status
History of fall 199 26 (13.1) 1.83 (1.13–2.96)
Number of independent IADL
7 798 41 (5.1) 1 (Reference)
6–3 628 31 (4.9) 0.86 (0.53–1.39)
2–0 260 41 (15.8) 2.59 (1.61–4.16)†
CI = Confidence interval, OR = odds ratio, COPD = chronic obstructive pulmonary disease, CIRS = Cumulative Illness Rating Scale, HAMT = Hodkinson
Abbreviated Mental Test, GDS = Geriatric Depression Scale
*Adjusted for age and IADL preadmission functional status
†P<.1
Table 3. Multivariable Logistic Regression Analyses Predicting New BADL Disability at Hospital Discharge
Variables Full model P value Most parsimonious model* P value Bootstrap estimation
OR (95% CI) OR (95% CI) 95% CI
Age
65–74 1 (Reference) – 1 (Reference) –
75–84 1.76 (1.01–3.07) 0.046 1.94 (1.12–3.34) 0.017 (1.06–3.36)
≥84 2.24 (1.21–4.16) 0.010 2.75 (1.52–4.97) 0.001 (1.44–4.76)
Nursing home resident 4.50 (1.68–12.1) 0.003 4.75 (1.80–12.6) 0.002 (1.15–13.3)
BMI
<18.5 2.32 (0.93–5.78) 0.070 3.41 (1.49–7.81) 0.004 (1.04–7.27)
18.5–24.9 1 (Reference) 1 (Reference)
25–29.9 0.63 (0.34–1.18) 0.152
≥30 0.77 (0.34–1.75) 0.537
Missing 4.11 (2.28–7.40) <0.001 5.50 (3.36–8.99) <0.001 (3.04–8.27)
Albumin
<3.5 g/dL 1.39 (0.80–2.43) 0.245
Total cholesterol (mg/dL)
<160 1 (Reference)
160–199 1.05 (0.55–2.00) 0.882
200–239 0.70 (0.32–1.54) 0.374
≥240 0.95 (0.38–2.42) 0.920
Erythrocyte sedimentation rate
≥40 mm/h 1.60 (0.98–2.62) 0.062 1.75 (1.11–2.75) 0.016 (1.02–2.73)
Pneumonia 1.65 (0.63–4.32) 0.304
Stroke 6.72 (2.87–15.8) <0.001 6.32 (2.75–14.5) <0.001 (2.21–14.9)
Antipsychotic 1.92 (0.85–4.33) 0.117
Number of medications
0–4 1 (Reference) 1 (Reference)
5–7 1.32 (0.62–2.83) 0.476
≥8 2.06 (1.03–4.13) 0.041 1.95 (1.24–3.06) 0.004 (1.18–2.86)
Total CIRS score
0–6 1 (Reference) 1 (Reference)
7–9 2.00 (1.13–3.50) 0.018 2.06(1.17–3.60) 0.012 (1.21–3.52)
≥10 2.12 (1.16–3.91) 0.014 2.17(1.21–3.89) 0.010 (1.28–3.80)
Cognitive decline (HAMT <7) 1.75 (1.08–2.83) 0.023 2.01 (1.28–3.15) 0.012 (1.11–2.82)
History of fall 1.75 (1.01–3.04) 0.046 1.73 (1.01–2.94) 0.045 (0.91–2.91)
Number of independent IADL
7 1 (Reference)
6–3 0.92 (0.54–1.58 0.758
0–2 1.39 (0.80–2.46) 0.252
For variables removed from the initial model, OR and 95% CI are not displayed in table. Variables included in the initial model are all the same variables
included in the full model.
OR = odds ratio, CI = Confidence interval, CIRS = Cumulative Illness Rating Scale, HAMT = Hodkinson Abbreviated Mental Test
*Backward stepwise logistic regression model (P value for removal >0.1).
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ences in terms of patients’ characteristics and study outcomes,
age, functional status, and cognitive function were consistent-
ly reported as major predictors.
10 In agreement with these
findings, our study reinforces the role of older age, cognitive
impairment, and prehospital functional status as risk factors
for new BADL disability. With regard to functional status, we
found that history of fall in the previous year was associated
with the risk of disability independent of other clinical
characteristics and baseline IADL status. The risk of fall
increases with age and is strongly associated with functional
limitation, comorbidity, frailty, and presence of subclinical
neurological dysfunction,
20,21 suggesting that among nondis-
abled older persons a recent history of fall might identify
subjects at higher risk of functional decline.
BMI and Biomarkers
Low BMI but not overweight or obesity was associated with the
risk of incident BADL disability. In the general population BMI
is considered an indirect but clinically useful measure of
adiposity. In the older population, however, because of the
age-related anthropometric changes, the relationship of BMI
with fat mass is less defined and low BMI is considered a better
indicator of reduced lean mass.
22 In older persons, low BMI
has been associated with increased risk of all-cause mortality
and involuntary weight loss has been proposed as diagnostic
criteria for the frailty syndrome.
19,23,24 Nevertheless, the
relationship between low BMI and functional limitation or
disability has gained less attention. Our finding suggests that
older patients with low BMI might be at higher risk of
functional decline as a consequence of reduced lean body
mass and presence of sarcopenia.
25 We evaluated the potential
role of several biological markers that have been suggested as
biomarkers of frailty or risk factors for disability.
26–28 Elevated
erythrocyte sedimentation rate, an unspecific but sensitive
marker of inflammation, was associated with a 75% increased
risk of disability. Several acute and chronic conditions are
associated with elevated erythrocyte sedimentation rate. How-
ever, in our analysis, the association between elevated eryth-
rocyte sedimentation rate and risk of disability was
independent of a number of potential confounders, including
comorbidity and multiple diseases. Recent epidemiological
studies have demonstrated that inflammatory markers are
powerful risk factors for mortality and disability in older
persons.
29–31 Our study extends these previous findings to
the clinical setting and reinforces the concept that older
persons with low-grade inflammation have reduced functional
reserve and are at high risk for multiple clinical outcomes.
Clinical Conditions and Comorbidity
This study confirms that comorbidity is associated with an
increased risk of functional decline during hospitalization. Our
findings, however, highlight the importance of evaluating the
global burden and the severity of diseases because a higher
value of the CIRS score was significantly and independently
associated with the risk of new BADL disability. It has been
demonstrated that nondisabled persons with poor objective
tests of lower extremity function have a greater prevalence of
chronic diseases;
32 it is likely therefore that patients with
higher comorbidity, although not yet disabled, were character-
ized by lower level of functional reserve and homeostatic
capacity. Moreover, a high number of medications used during
hospitalization was independently associated with an in-
creased risk of functional decline. Conversely, among the
different single diseases evaluated, only acute stroke was
significantly related with the risk of new disability. Globally
taken, these results suggest that a disease-oriented approach
might underestimate the risk of functional decline in the
hospital setting.
Limitations
This study has important limitations. Functional status was
not assessed at the time of hospital admission. It has been
demonstrated that functional status of older patients can
decline just before hospital admission and that some patients
can regain functional independence between admission and
discharge.
2 From this point of view our study design allowed
only for a limited picture of patients’ functional trajectory. We
did not collect information on hospital characteristics and
rehabilitation treatments that might influence functional
trajectory of older patients. For selected variables there was a
substantial rate of missing data. For cholesterol, albumin, and
erythrocyte sedimentation rate, patients with missing data had
a risk of functional decline that was similar and not statisti-
cally significant when compared with the reference category.
Analysis performed after exclusion of subjects with missing
data on these variables did not change the results (data not
shown). Conversely, patients with missing BMI had a higher
probability of functional decline. It is likely that these patients
had mobility limitation at hospital admission. Exclusion of this
subgroup of patient did not change the point estimate of most
of the variables but substantially reduced the statistical power
and the likelihood of finding significant associations. For this
reason we decided to present the result of the analysis
including all the patients considered in the study.
Conclusions
This study shows that, besides acute illnesses, several factors
might contribute to the loss of physical independence often
experienced by older patients during hospitalization. Pre-
existing characteristics associated with the frailty syndrome,
including physical and cognitive function, comorbidity, body
composition, and inflammatory markers, are important pre-
dictors. We believe that these findings might have a twofold
implication; understanding the characteristics of patients who
develop new disability might help us in understanding the
biological mechanism underlying the hospital-related loss of
physical function. Furthermore, primary and secondary pre-
vention of functional decline is a basic goal of geriatric care
also in the acute setting. From a practical point of view,
screening and early identification of patients at higher risk is
the first step of this process. Our findings identified a set of
simple characteristics, readily available to clinicians that
might by helpful for a more efficient risk stratification leading
to prompt implementation of preventive strategies and optimal
planning of hospital and postdischarge care.
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